.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Medtronic
Covington
Johnson and Johnson
AstraZeneca
Accenture
Daiichi Sankyo
Moodys
Argus Health
Colorcon

Generated: September 23, 2017

DrugPatentWatch Database Preview

MAXOLON Drug Profile

« Back to Dashboard

What is the patent landscape for Maxolon, and what generic Maxolon alternatives are available?

Maxolon is a drug marketed by King Pharms and is included in one NDA.

The generic ingredient in MAXOLON is metoclopramide hydrochloride. There are twelve drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the metoclopramide hydrochloride profile page.

Summary for Tradename: MAXOLON

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list98
Clinical Trials: see list3
Patent Applications: see list53
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MAXOLON at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
King Pharms
MAXOLON
metoclopramide hydrochloride
TABLET;ORAL070106-001Mar 4, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
McKinsey
Dow
Boehringer Ingelheim
Argus Health
Healthtrust
Cantor Fitzgerald
Covington
Novartis
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot